Related Experiment Video
Updated: Mar 23, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Leveraging protein quaternary structure to identify oncogenic driver mutations
Gregory A Ryslik1, Yuwei Cheng2, Yorgo Modis3
1Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA. gregory.ryslik@yale.edu.
Background:
Identifying key "driver" mutations which are responsible for tumorigenesis is critical in the development of new oncology drugs. Due to multiple pharmacological successes in treating cancers that are caused by such driver mutations, a large body of methods have been developed to differentiate these mutations from the benign "passenger" mutations which occur in the tumor but do not further progress the disease. Under the hypothesis that driver mutations tend to cluster in key regions of the protein, the development of algorithms that identify these clusters has become a critical area of research.
Results:
We have developed a novel methodology, QuartPAC (Quaternary Protein Amino acid Clustering), that identifies non-random mutational clustering while utilizing the protein quaternary structure in 3D space. By integrating the spatial information in the Protein Data Bank (PDB) and the mutational data in the Catalogue of Somatic Mutations in Cancer (COSMIC), QuartPAC is able to identify clusters which are otherwise missed in a variety of proteins. The R package is available on Bioconductor at: http://bioconductor.jp/packages/3.1/bioc/html/QuartPAC.html .
Conclusion:
QuartPAC provides a unique tool to identify mutational clustering while accounting for the complete folded protein quaternary structure.
Insights
Identifying cancer driver mutations is crucial for oncology drug development. Our new QuartPAC method effectively detects mutation clusters in protein structures, improving cancer research.
Area of Science:
- Computational Biology
- Genomics
- Structural Biology
Background:
- Identifying cancer-causing "driver" mutations is essential for targeted oncology drug development.
- Distinguishing driver mutations from benign "passenger" mutations is a significant challenge in cancer research.
- Driver mutations are hypothesized to cluster in specific protein regions, driving research into clustering algorithms.
Purpose of the Study:
- To develop a novel computational methodology for identifying non-random mutational clustering in proteins.
- To leverage protein quaternary structure in three-dimensional space for mutation analysis.
- To improve the detection of functionally significant mutation clusters in cancer.
Main Methods:
- Developed QuartPAC (Quaternary Protein Amino acid Clustering), a novel methodology.
- Integrated spatial data from the Protein Data Bank (PDB).
- Incorporated mutational data from the Catalogue of Somatic Mutations in Cancer (COSMIC).
Main Results:
- QuartPAC identifies non-random mutational clusters using protein quaternary structure.
- The method detects clusters missed by existing approaches.
- Demonstrated utility across various proteins by integrating PDB and COSMIC data.
Conclusions:
- QuartPAC offers a unique computational tool for identifying mutational clustering.
- The methodology accounts for complete protein quaternary structure in its analysis.
- Provides a valuable approach for cancer driver mutation research.
More Related Videos
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes

